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INTRODUCTION
NR2E3 is a gene that encodes for photoreceptor cell specific nuclear receptor, which is involved in cone proliferation (Kobayashi M et al. 1999 ). It targets rhodopsin and several other opsins, which are important for sight (Milam AH et al. 2002) . It is predicted to affect normal protein splicing. NR2E3 mutations lead to macular schisis, with an increase in functional S cone-like cells, thickening of retinal layers, loss of retinal lamination, S and L cone function.
CASE
A 44 year-old man presented to the eye clinic with the chief complaint of decreased vision in the right eye for the past 6 months and nonprogressive lifelong difficulty of seeing in the dark. His visual acuity was 6/6 in the right eye and hand movement close to face in the left eye.
Fundus examination of the right eye revealed a slightly pale tilted optic disc, retinal pigmentary changes in the mid periphery, thin vessels, partial vitreous detachment and cystic changes in the macula (Fig 1.a) . Left eye fundus examination revealed vitreous haze, a pigmented macular scar with and long-standing inferior retinal detachment (Fig 1.a) (Fig 1.a) . OCT revealed mild A novel NR2E3 gene mutation in a patient with autosomal recessive retinitis pigmentosa February 8, 2017
3 thickening in the right eye with a cystic lesion in the right macula (Fig   1.b) . A possible diagnosis of retinoschisis was made and he was screened for mutation in the RSI gene, which turned out to be negative. His visual acuity in the right eye dropped to 6/36. He was prescribed Diamox (500mg po bd). His vision improved to 6/9 with the resolution of cysts after treatment with Diamox for 11 months. 6 months after discontinuing Diamox tablets, cystic spaces in the right macula increased again but the vision was stable and the patient was not keen to take Diamox because of its side effects (Fig 1.b) . His present vision in the right eye is 6/9 and perception of light in the left eye. OCT shows minimal residual cysts in the right eye (Fig 1.b) .
The results of the retinal panel that was screened for 176 genes associated with retinal dystrophies by next generation sequencing revealed the heterozygous NR2E3 changes,(c.119-2A>C and c.571+2T>C) (OMIM *604485). There was no family history of inherited retinal dystrophy. Mother's DNA had the same mutation but it was heterozygous, suggesting that she was a carrier. The mutation was in the trans form. The father's DNA could not be tested, as he is no longer living. A diagnosis of autosomal recessive retinitis pigmentosa with cystic maculopathy, caused by compound heterozygous mutation in the gene NR2E3 was made. 0.25% cases of ARRP in Caucasians are ascribed to NR2E3 gene mutations. However, the mutation c 571 + 2 T > C in NR2E3 has not been previously reported with retinal disease. The prevalence of cystoid macular edema is about 10% to 15% in RP (Adackapara CA et al. 2008) and carbonic anhydrase inhibitors enhance sub retinal fluid absorption in macular edema. Their usefulness was proven in the treatment of macular cystoid changes (Nagelhus EA et al. 2005 & Ikeda Y et al. 2012 . With the advent of clinical trials for inherited retinal dystrophies, it is important to identify the genes in retinal dystrophies to facilitate the development of new therapeutic interventions. 
DISCUSSION

